Local Indicator & Definition | WHO targets | Data collection | Provisional figures |
---|---|---|---|
|
- | Population Health Survey by DH and literature review | 7.2% (2016) [20] 6.4% (2016) [21] |
|
- | 0.5% (Anti-HCV+, 2016) [20] 0.3% (HCV RNA+, 2016) [20] 0.2% (HCV RNA+, 2015) [22] |
|
|
By 2020: 50% ; By 2030: 90% |
Statistics on administration of timely hepatitis B vaccine birth dose, regularly collected by DH | >95%3 |
|
By 2020: 90% ; By 2030: 90% |
Immunisation Survey on Preschool Children by DH as proxy | Coverage Pre-school children 99.7%in 2018 [89] 99.2% in 2015 [90] Timeliness[89] Local children: 6.2 (IQR 6.1-6.4) months Non-local children: 6.4 (IQR 6.2-6.9) months |
|
By 2020: 30% ; By 2030: 90% |
Population Health Survey by DH and estimation from clinical and laboratory records in HA | - |
|
80% of eligible persons with chronic HBV infection treated by 2030 | Clinical, laboratory and prescription records in HA | - |
|
80% of eligible persons with chronic HCV infection treated by 2030 | - | |
|
- | - | |
|
- | - | |
|
By 2020: 30% reduction6; By 2030: 90% reduction7 (as compared with the baseline number in 2015) |
Biomarker survey or mathematical modelling | 0.78% (children aged 12 – 15 years in 2009) [18] |
|
By 2020: 30% reduction; By 2030: 90% reduction (as compared with the baseline number in 2015) |
Modelling with inputs from repeated surveys, including Population Health Survey by DH and published studies among PWID and MSM | Number of reported acute cases: 34 (2018) 18 (2017) 39 (2016) 14 (2015) |
|
By 2020: 10% reduction; By 2030: 65% reduction (as compared with the baseline number in 2015) |
Review of death statistics in DH to identify related deaths; Attributable fraction to HBV and HCV by reviewing their respective clinical and/or laboratory records in HA | - |
1 Defined by HBsAg-positive serological status
2 Defined as positive for HCV RNA or HCV Ag
3 WHO-UNICEF Joint Reporting Form (data for 2019)
4 HBV DNA not detectable, based on VL measurement in the past 12 months
5 Based on VL measurement 12-24 weeks after the end of treatment (in the past 12 months)
6 Equivalent to 1% prevalence of HBsAg among children
7 Equivalent to 0.1% prevalence of HBsAg among children
8 Defined as anti-HCV positive per year
Terms of Reference
Co-chairpersons
Dr. CHAN Hon-yee, Constance, JP
Dr. LEUNG Pak-yin, JP (till July 2019)
Dr. KO Pat-sing, Tony (since August 2019)
Members
Prof. CHAN Lik-yuen, Henry
Dr. CHAN Chi-wai, Rickjason (since April 2019)
Dr. CHAN Ming-wai, Angus
Dr. HO Ka-wai, Rita (till February 2019)
Dr. LO Yee-chi, Janice (till March 2019)
Dr. LO Yim-chong (since February 2019)
Dr. LAI Sik-to
Dr. LAO Wai-cheung
Prof. LAU Yu-lung
Prof. LEE Shui-shan
Dr. LEUNG Wai-yee, Nancy (till July 2020)
Dr. LEUNG Wing-cheong
Dr. TSANG Tak-yin, Owen
Prof. YUEN Man-fung
Ex-officio members
Dr. WONG Ka-hing, JP
Dr. CHUNG Kin-lai
Mr. CHAN Wai-kee, Howard, JP
Secretary
Dr. CHAN Chi-wai, Kenny (till November 2018)
Dr. LAM Kit-yi, Rebecca (since November 2018)
Terms of Reference
Convenor
Dr LAU Ka-hin (since June 2019)
Dr SO Wing-yee (till June 2019)
Members
Dr. CHAN Chi-wai, Kenny
(till November 2018)
Dr. Chan Man-chi, Grace
(since May 2020)
Dr. CHAN Ming-wai, Angus
Dr. CHAN Pang-fai
Dr. FUNG Yan-yue, James
Dr. HUI Yee-tak
Dr. KAN Yee-ling, Elaine
Dr. KWAN Yat-wah, Mike
Mr. KWONG Yiu-sum, Benjamin
(till May 2020)
Dr. LAM Kit-yi, Rebecca
(since November 2018)
Dr. LAO Wai-cheung
Dr. LAW Chun-bon
(till December 2019)
Dr. WONG Han, Ann
Prof. WONG Wai-sun, Vincent
Co-opt members
Ms. CHEUNG Kar-yee, Celia
(till November 2019)
Mr. CHEUNG Tak-lun, Alan
(since November 2019)
Dr. FUNG Wai-kwan, Barbara
Dr. LEUNG Wing-cheong
Ms. TSUI Lai-hing, Eva
Dr. WOO Pao-sun, Pauline
(till August 2019)
Secretary
Ms. CHAN Sin-yee, May
Terms of Reference
Convenor
Dr. CHAN Chi-wai, Kenny (till November 2018)
Dr. LAM Kit-yi, Rebecca (since November 2018)
Members
Dr. CHAN Chi-wai, Rickjason (since April 2019)
Dr. CHEN Hong (since December 2019)
Dr. LAU Ka-hin (since June 2019)
Dr. LEUNG Oi-shan, Joanna
Dr. LO Yee-chi, Janice (till March 2019)
Dr. SO Wing-yee (till June 2019)
Dr. TSANG Chiu-yin, Chester
Dr. WONG Miu-ling
Dr. WONG Tin-yau, Andrew (till December 2019)
Co-opt members
Ms. CHEUNG Kar-yee, Celia (till November 2019)
Mr. CHEUNG Tak-lun, Alan (since November 2019)
Dr. WOO Pao-sun, Pauline (till August 2019)
Secretary
Dr. KWOK Lai-key, Priscilla (since January 2019)
Dr. WONG Chun-kwan, Bonnie (till January 2019)